PROPANC BIOPHARMA INC (PPCB) Stock Technical Analysis
USA - NASDAQ:PPCB - US74346N7012 - Common Stock
Taking everything into account, PPCB scores 2 out of 10 in our technical rating. PPCB performed below average in the overall market. Although the medium term picture in unclear, the short term picture is clearly negative.
The technical rating of PPCB is bad and it also does not present a quality setup at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
1.95
We found 1 important support area.
- A support zone ranging from 1.97 to 1.99. This zone is formed by a combination of multiple trend lines in multiple time frames.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for PPCB is up. |
| ChartMill Short Term Trend Indicator | NEUTRAL | NEUTRAL | The short term trend for PPCB is neutral. |
| ChartMill Relative Strength | 0 | NEGATIVE | PPCB has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Relative Strength Index/RSI (14) | 39.9 | NEUTRAL | The RSI value for PPCB is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.23 | NEGATIVE | The MACD value suggests PPCB has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 7.34 | OVERSOLD | The low Stochastics value suggests PPCB may be oversold. |
| Average Directional Index/ADX (14) | 11.62 | NEGATIVE | The low ADX value for PPCB suggests a weak or negative trend. |
NASDAQ:PPCB (9/12/2025, 10:41:23 AM)
2.21
+0.23 (+11.62%)